Total number of protein in "GO:0032809" GO term: 30
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADCY8-201 | ADCY8 | P40145 | Adenylate cyclase type 8 | chr8 | GO:0032809 | Not Cancer Driver | No | 358 | 0.2861710631494804 | 215 | 31 | 0.0247801758593125 | 0 |
AMIGO1-202 | AMIGO1 | Q86WK6 | Amphoterin-induced protein 1 | chr1 | GO:0032809 | Not Cancer Driver | No | 37 | 0.075050709939148 | 85 | 5 | 0.0101419878296146 | 0 |
ATP1A3-214 | ATP1A3 | P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | chr19 | GO:0032809 | Not Cancer Driver | No | 151 | 0.1490621915103652 | 116 | 21 | 0.0207305034550839 | 41 |
ATP2B2-202 | ATP2B2 | Q01814 | Plasma membrane calcium-transporting ATPase 2 | chr3 | GO:0032809 | Not Cancer Driver | No | 206 | 0.165728077232502 | 362 | 68 | 0.0547063555913113 | 0 |
CADM2-203 | CADM2 | Q8N3J6 | Cell adhesion molecule 2 | chr3 | GO:0032809 | Not Cancer Driver | No | 0 | 0.0 | 120 | 0 | 0.0 | 0 |
CD22-201 | CD22 | P20273 | B-cell receptor CD22 | chr19 | GO:0032809 | Not Cancer Driver | No | 126 | 0.1487603305785124 | 293 | 50 | 0.0590318772136954 | 0 |
CX3CR1-202 | CX3CR1 | P49238 | CX3C chemokine receptor 1 | chr3 | GO:0032809 | Not Cancer Driver | No | 60 | 0.1690140845070422 | 0 | 0 | 0.0 | 0 |
DAB2IP-203 | DAB2IP | Q5VWQ8 | Disabled homolog 2-interacting protein | chr9 | GO:0032809 | Not Cancer Driver | No | 95 | 0.0798990748528175 | 682 | 49 | 0.04121110176619 | 0 |
ENST00000644613 | ATP1A3 | P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | chr19 | GO:0032809 | Not Cancer Driver | No | 151 | 0.1495049504950495 | 115 | 21 | 0.0207920792079207 | 39 |
FLRT1-202 | FLRT1 | Q9NZU1 | Leucine-rich repeat transmembrane protein FLRT1 | chr11 | GO:0032809 | Not Cancer Driver | No | 58 | 0.086053412462908 | 95 | 5 | 0.0074183976261127 | 0 |
GABRA5-201 | GABRA5 | P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | chr15 | GO:0032809 | Not Cancer Driver | No | 117 | 0.2532467532467532 | 55 | 16 | 0.0346320346320346 | 2 |
GRIA1-201 | GRIA1 | P42261 | Glutamate receptor 1 | chr5 | GO:0032809 | Not Cancer Driver | No | 252 | 0.2781456953642384 | 104 | 37 | 0.0408388520971302 | 3 |
HPCA-201 | HPCA | P84074 | Neuron-specific calcium-binding protein hippocalcin | chr1 | GO:0032809 | Not Cancer Driver | No | 19 | 0.0984455958549222 | 42 | 4 | 0.0207253886010362 | 3 |
INSR-201 | INSR | P06213 | Insulin receptor | chr19 | GO:0032809 | Not Cancer Driver | No | 139 | 0.1005788712011577 | 282 | 37 | 0.0267727930535455 | 63 |
KCNA2-201 | KCNA2 | P16389 | Potassium voltage-gated channel subfamily A member 2 | chr1 | GO:0032809 | Not Cancer Driver | No | 76 | 0.1523046092184369 | 83 | 12 | 0.0240480961923847 | 6 |
KCNB1-201 | KCNB1 | Q14721 | Potassium voltage-gated channel subfamily B member 1 | chr20 | GO:0032809 | Not Cancer Driver | No | 154 | 0.1794871794871795 | 417 | 82 | 0.0955710955710955 | 6 |
KCNB2-201 | KCNB2 | Q92953 | Potassium voltage-gated channel subfamily B member 2 | chr8 | GO:0032809 | Not Cancer Driver | No | 323 | 0.3545554335894621 | 503 | 181 | 0.1986827661909989 | 0 |
KCNC1-202 | KCNC1 | P48547 | Potassium voltage-gated channel subfamily C member 1 | chr11 | GO:0032809 | Not Cancer Driver | No | 67 | 0.1311154598825831 | 111 | 11 | 0.0215264187866927 | 1 |
KCNC2-208 | KCNC2 | Q96PR1 | Potassium voltage-gated channel subfamily C member 2 | chr12 | GO:0032809 | Not Cancer Driver | No | 131 | 0.2053291536050156 | 255 | 49 | 0.0768025078369906 | 8 |
KCNC3-203 | KCNC3 | Q14003 | Potassium voltage-gated channel subfamily C member 3 | chr19 | GO:0032809 | Not Cancer Driver | No | 51 | 0.0673712021136063 | 405 | 20 | 0.0264200792602377 | 4 |
KCNC4-206 | KCNC4 | Q03721 | Potassium voltage-gated channel subfamily C member 4 | chr1 | GO:0032809 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
KCND2-201 | KCND2 | Q9NZV8 | Potassium voltage-gated channel subfamily D member 2 | chr7 | GO:0032809 | Not Cancer Driver | No | 175 | 0.2777777777777778 | 195 | 51 | 0.0809523809523809 | 1 |
KCNE3-201 | KCNE3 | Q9Y6H6 | Potassium voltage-gated channel subfamily E member 3 | chr11 | GO:0032809 | Not Cancer Driver | No | 25 | 0.2427184466019417 | 25 | 2 | 0.0194174757281553 | 0 |
RGS8-207 | RGS8 | P57771 | Regulator of G-protein signaling 8 | chr1 | GO:0032809 | Not Cancer Driver | No | 31 | 0.1722222222222222 | 21 | 5 | 0.0277777777777777 | 0 |
SLC4A8-203 | SLC4A8 | Q2Y0W8 | Electroneutral sodium bicarbonate exchanger 1 | chr12 | GO:0032809 | Not Cancer Driver | No | 127 | 0.1161939615736505 | 276 | 32 | 0.0292772186642269 | 0 |
SLC6A2-208 | SLC6A2 | P23975 | Sodium-dependent noradrenaline transporter | chr16 | GO:0032809 | Not Cancer Driver | No | 98 | 0.1588330632090761 | 23 | 6 | 0.0097244732576985 | 1 |
SLC6A3-201 | SLC6A3 | Q01959 | Sodium-dependent dopamine transporter | chr5 | GO:0032809 | Not Cancer Driver | No | 131 | 0.2112903225806451 | 31 | 5 | 0.0080645161290322 | 2 |
TACR3-201 | TACR3 | P29371 | Neuromedin-K receptor | chr4 | GO:0032809 | Not Cancer Driver | No | 116 | 0.2494623655913978 | 31 | 17 | 0.0365591397849462 | 5 |
THY1-201 | THY1 | P04216 | Thy-1 membrane glycoprotein | chr11 | GO:0032809 | Not Cancer Driver | No | 23 | 0.1428571428571428 | 5 | 0 | 0.0 | 0 |
UNC5A-201 | UNC5A | Q6ZN44 | Netrin receptor UNC5A | chr5 | GO:0032809 | Not Cancer Driver | No | 99 | 0.1175771971496437 | 120 | 14 | 0.0166270783847981 | 0 |